Small EJ - Search Results

1

Impact of ⁶⁸Ga-PSMA-11 PET on Management in Patients with Biochemically Recurrent Prostate Cancer.

Hope TA, Aggarwal R, Chee B, Tao D, Greene KL, Cooperberg MR, Feng F, Chang A, Ryan CJ, Small EJ, Carroll PR. Hope TA, et al. Among authors: small ej. J Nucl Med. 2017 Dec;58(12):1956-1961. doi: 10.2967/jnumed.117.192476. Epub 2017 May 18. J Nucl Med. 2017. PMID: 28522741 Free article.

2

Prostate cancer: who to screen, and what the results mean.

Small EJ. Small EJ. Geriatrics. 1993 Dec;48(12):28-30, 35-8. Geriatrics. 1993. PMID: 7504646 Review.

3

Prostate-specific antigen decline after casodex withdrawal: evidence for an antiandrogen withdrawal syndrome.

Small EJ, Carroll PR. Small EJ, et al. Urology. 1994 Mar;43(3):408-10. doi: 10.1016/0090-4295(94)90092-2. Urology. 1994. PMID: 7510915

4

A phase I/II study of alternating constant rate infusion floxuridine with constant rate infusion vinblastine for the treatment of metastatic renal cell carcinoma.

Small EJ, Frye JW, Wilkinson MJ, Carroll PR, Ernest ML, Stagg RJ. Small EJ, et al. Cancer. 1994 Jun 1;73(11):2803-7. doi: 10.1002/1097-0142(19940601)73:11<2803::aid-cncr2820731124>3.0.co;2-6. Cancer. 1994. PMID: 8194022 Clinical Trial.

5

Nephrectomy for metastatic renal cell carcinoma: a component of systemic treatment regimens.

Wolf JS Jr, Aronson FR, Small EJ, Carroll PR. Wolf JS Jr, et al. Among authors: small ej. J Surg Oncol. 1994 Jan;55(1):7-13. doi: 10.1002/jso.2930550104. J Surg Oncol. 1994. PMID: 8289458

6

A phase II study of constant-infusion floxuridine for the treatment of metastatic renal cell carcinoma.

Wilkinson MJ, Frye JW, Small EJ, Venook AP, Carroll PR, Ernest ML, Stagg RJ. Wilkinson MJ, et al. Among authors: small ej. Cancer. 1993 Jun 1;71(11):3601-4. doi: 10.1002/1097-0142(19930601)71:11<3601::aid-cncr2820711122>3.0.co;2-#. Cancer. 1993. PMID: 8490909 Clinical Trial.

7

Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization and allelotyping.

Cher ML, Bova GS, Moore DH, Small EJ, Carroll PR, Pin SS, Epstein JI, Isaacs WB, Jensen RH. Cher ML, et al. Among authors: small ej. Cancer Res. 1996 Jul 1;56(13):3091-102. Cancer Res. 1996. PMID: 8674067

8

A carboplatin-based regimen for the treatment of patients with advanced transitional cell carcinoma of the urothelium.

Small EJ, Fippin LJ, Ernest ML, Carroll PR. Small EJ, et al. Cancer. 1996 Oct 15;78(8):1775-80. doi: 10.1002/(sici)1097-0142(19961015)78:8<1775::aid-cncr18>3.0.co;2-v. Cancer. 1996. PMID: 8859191 Clinical Trial.

9

Second-line hormonal therapy for advanced prostate cancer: a shifting paradigm.

Small EJ, Vogelzang NJ. Small EJ, et al. J Clin Oncol. 1997 Jan;15(1):382-8. doi: 10.1200/JCO.1997.15.1.382. J Clin Oncol. 1997. PMID: 8996165 Review.

10

Focal therapy for prostate cancer 1996: maximizing outcome.

Carroll PR, Presti JC Jr, Small E, Roach M 3rd. Carroll PR, et al. Urology. 1997 Mar;49(3A Suppl):84-94. doi: 10.1016/s0090-4295(97)00174-x. Urology. 1997. PMID: 9123742 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

477 results

Search Page

Filters